Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Mometasone furoate · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Mometasone furoate | DRUG | - |
| Formoterol fumarate | DRUG | - |
Inclusion Criteria: * Healthy, male or female subjects age 18 to 65 years of age (included) * In good health as confirmed by past medical history * Female subjects must be either surgically sterilized at least 6 months prior to study participation or post-menopausal (no regular menstrual bleeding f...
Mometasone furoate is an investigational small molecule being studied for use in asthma and in healthy volunteers. It is being developed by Novartis AG (NVS). Clinical trials have evaluated it in patients with persistent asthma, including children, adolescents, and adults, as well as in healthy adult volunteers.
Mometasone furoate is a corticosteroid that works by reducing inflammation in the airways. It is being studied in combination with other inhaled medications, such as formoterol fumarate and indacaterol, for the treatment of asthma. The drug is delivered via inhalation devices.
Mometasone furoate is being developed by Novartis AG, a global healthcare company traded under the ticker NVS. Novartis has sponsored multiple clinical trials investigating the drug for asthma and in healthy volunteers.
Mometasone furoate is in clinical development, with trials listed as Phase 1 and Phase 2. It is not approved and remains investigational. Three trials have been completed, and no active trials are currently listed.
Mometasone furoate has been studied in three completed trials: NCT00418509 in healthy volunteers, NCT00746330 in children with persistent asthma, NCT01555151 in adults and adolescents with asthma, and NCT04589663 in children with asthma. These trials evaluated safety, efficacy, and pharmacokinetics.
No, Mometasone furoate is a separate drug, a corticosteroid. It has been studied in combination with formoterol fumarate and with indacaterol, which are bronchodilators. The trials listed evaluate the combination products, not Mometasone furoate alone.